JAJaguar Health JAGX · NASDAQ
$2.04 -5.12% (-$0.11)
- Market cap
- $4.18M
- Enterprise value
- $17.0M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- 0.2x
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -118.2%
- Gross margin
- 82.3%
- Net margin
- -132.0%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -
- Beta
- -0.06
- Free float
- 93.8%
About the company
Jaguar Health, Inc. (JAGX) is an American company focused on researching, developing, and commercializing pharmaceuticals and natural medicines for veterinary and human health. The company specializes in treating various gastrointestinal disorders, such as diarrhea and other digestive issues, in both animals and humans. Jaguar Health aims to utilize natural resources and innovative technologies to develop safe and effective therapeutic solutions. The company also has research projects focused on the prevention and treatment of other health conditions. Shares of Jaguar Health, Inc. (JAGX) can represent an interesting investment opportunity for investors who follow innovations in healthcare and pharmaceuticals and seek investments in the biotechnology sector.
Sector
Healthcare
Industry
Biotechnology
CEO
Lisa A. Conte
Employees
47
Headquarters
San Francisco
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number